MiMedx Group MDXG Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $58.99M-50.0% | $118.1M+3.8% | $113.73M+15.3% | $98.61M+11.8% | $88.21M-5.1% | ||
| $17.37M-8.9% | $19.06M+1.8% | $18.72M+0.2% | $18.68M+12.8% | $16.56M-2.1% | ||
| $41.62M-58.0% | $99.04M+4.2% | $95.01M+18.9% | $79.92M+11.6% | $71.65M-5.7% | ||
| 70.6%-13.3pp | 83.9%+0.3pp | 83.5%+2.5pp | 81.1%-0.2pp | 81.2%-0.6pp | ||
| $4.14M-13.0% | $4.76M+28.6% | $3.7M+12.1% | $3.3M-0.8% | $3.33M-6.8% | ||
| $53.23M-27.2% | $73.07M+5.9% | $69M+7.6% | $64.15M+7.0% | $59.97M-1.8% | ||
| $301K+133% | $129K+15.2% | $112K+12.0% | $100K+1.0% | $99K-48.7% | ||
| -$16.05M-176% | $21.08M-5.0% | $22.19M+79.4% | $12.37M+49.9% | $8.25M-25.4% | ||
| -27.2%-45.1pp | 17.8%-1.7pp | 19.5%+7.0pp | 12.5%+3.2pp | 9.4%-2.5pp | ||
| $886K-2.0% | $904K+15.2% | $785K+6.4% | $738K+45.8% | $506K— | ||
| -$168K+9.7% | -$186K-47.6% | -$126K-24.8% | -$101K+30.3% | -$145K+30.3% | ||
| -$15.33M-170% | $21.8M-4.6% | $22.85M+75.7% | $13.01M+51.0% | $8.61M-23.4% | ||
| -$4.47M-168% | $6.6M+8.2% | $6.1M+80.0% | $3.39M+113% | $1.59M-58.3% | ||
| -$0.07-170% | $0.10-9.1% | $0.11+83.3% | $0.06+20.0% | $0.050.0% | ||
| -$0.07-170% | $0.10-9.1% | $0.11+57.1% | $0.07+40.0% | $0.050.0% | ||
| 148.4M-0.9% | 149.7M0.0% | 149.7M+0.3% | 149.3M-0.2% | 149.7M+0.4% | ||
| 148.4M+0.4% | 147.8M-0.2% | 148M+0.2% | 147.8M+0.3% | 147.3M+0.2% | ||
| —— | $0— | $0— | $0— | $0+100% | ||
| $886K-2.0% | $904K+15.2% | $785K+6.4% | $738K+45.8% | $506K— | ||
| -$10.86M-171% | $15.19M-9.3% | $16.75M+74.1% | $9.62M+37.0% | $7.02M-5.6% | ||
| -$168K+9.7% | -$186K-47.6% | -$126K-24.8% | -$101K+30.3% | -$145K+30.3% | ||
| $58.99M-50.0% | $118.1M+3.8% | $113.73M+15.3% | $98.61M+11.8% | $88.21M-5.1% | ||
| -$16.05M-176% | $21.08M-5.0% | $22.19M+79.4% | $12.37M+49.9% | $8.25M-25.4% | ||
| -$15.75M-164% | $24.8M-4.3% | $25.91M+61.0% | $16.09M+34.4% | $11.97M-4.7% | ||
| -$15.75M-164% | $24.8M-4.3% | $25.91M+61.0% | $16.09M+34.4% | $11.97M-4.7% | ||
| -26.7%-47.7pp | 21%-1.8pp | 22.8%+6.5pp | 16.3%+2.7pp | 13.6%0.0pp | ||
| -$16.05M-176% | $21.08M-5.0% | $22.19M+79.4% | $12.37M+49.9% | $8.25M-25.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is MiMedx Group's revenue?
- MiMedx Group (MDXG) generated $389.4M in revenue over the trailing twelve months, up 10.5% year over year.
- Is MiMedx Group profitable?
- MiMedx Group reported $30.7M in net income over the trailing twelve months, a 7.9% net margin.
- What are MiMedx Group's profit margins?
- Gross margin is 81.0% and operating margin is 10.2%, with a 7.9% net margin.
- What is MiMedx Group's earnings per share?
- MiMedx Group's diluted EPS over the trailing twelve months is $0.20.
- Where does MiMedx Group's income statement data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
